Cargando…

MiRNome analysis identifying miR‐205 and miR‐449a as biomarkers of disease progression in intestinal‐type sinonasal adenocarcinoma

BACKGROUND: Patients with intestinal‐type sinonasal adenocarcinoma (ITAC) have an unfavorable prognosis, and new diagnostic and therapeutic approaches are needed to improve clinical management. METHODS: Next‐generation sequencing‐based miRNome analysis was performed on 43 ITAC patients who underwent...

Descripción completa

Detalles Bibliográficos
Autores principales: Re, Massimo, Tomasetti, Marco, Monaco, Federica, Amati, Monica, Rubini, Corrado, Sollini, Giacomo, Bajraktari, Arisa, Gioacchini, Federico Maria, Santarelli, Lory, Pasquini, Ernesto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292973/
https://www.ncbi.nlm.nih.gov/pubmed/34647653
http://dx.doi.org/10.1002/hed.26894
_version_ 1784749506007400448
author Re, Massimo
Tomasetti, Marco
Monaco, Federica
Amati, Monica
Rubini, Corrado
Sollini, Giacomo
Bajraktari, Arisa
Gioacchini, Federico Maria
Santarelli, Lory
Pasquini, Ernesto
author_facet Re, Massimo
Tomasetti, Marco
Monaco, Federica
Amati, Monica
Rubini, Corrado
Sollini, Giacomo
Bajraktari, Arisa
Gioacchini, Federico Maria
Santarelli, Lory
Pasquini, Ernesto
author_sort Re, Massimo
collection PubMed
description BACKGROUND: Patients with intestinal‐type sinonasal adenocarcinoma (ITAC) have an unfavorable prognosis, and new diagnostic and therapeutic approaches are needed to improve clinical management. METHODS: Next‐generation sequencing‐based miRNome analysis was performed on 43 ITAC patients who underwent surgical resection, and microRNA (miRNA) data were obtained from 35 cases. Four miRNAs were identified, and their expression levels were detected by reverse‐transcription quantitative polymerase chain reaction and related to the relevant patient outcome. Overall survival and disease‐free survival rates were evaluated through the Kaplan–Meier method and log‐rank test, and multivariate analysis was performed by means of Cox proportional hazard analysis. RESULTS: High levels of miR‐205 and miR‐34c/miR‐449 cluster expression were associated with an increased recurrence risk and, therefore, a worse prognosis. Multivariate analysis confirmed that miR‐205 and miR‐449 were significant prognostic predictors. CONCLUSIONS: A high expression of miR‐205 and miR‐449 is independent predictors of poor survival for ITAC patients.
format Online
Article
Text
id pubmed-9292973
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-92929732022-07-20 MiRNome analysis identifying miR‐205 and miR‐449a as biomarkers of disease progression in intestinal‐type sinonasal adenocarcinoma Re, Massimo Tomasetti, Marco Monaco, Federica Amati, Monica Rubini, Corrado Sollini, Giacomo Bajraktari, Arisa Gioacchini, Federico Maria Santarelli, Lory Pasquini, Ernesto Head Neck Original Articles BACKGROUND: Patients with intestinal‐type sinonasal adenocarcinoma (ITAC) have an unfavorable prognosis, and new diagnostic and therapeutic approaches are needed to improve clinical management. METHODS: Next‐generation sequencing‐based miRNome analysis was performed on 43 ITAC patients who underwent surgical resection, and microRNA (miRNA) data were obtained from 35 cases. Four miRNAs were identified, and their expression levels were detected by reverse‐transcription quantitative polymerase chain reaction and related to the relevant patient outcome. Overall survival and disease‐free survival rates were evaluated through the Kaplan–Meier method and log‐rank test, and multivariate analysis was performed by means of Cox proportional hazard analysis. RESULTS: High levels of miR‐205 and miR‐34c/miR‐449 cluster expression were associated with an increased recurrence risk and, therefore, a worse prognosis. Multivariate analysis confirmed that miR‐205 and miR‐449 were significant prognostic predictors. CONCLUSIONS: A high expression of miR‐205 and miR‐449 is independent predictors of poor survival for ITAC patients. John Wiley & Sons, Inc. 2021-10-14 2022-01 /pmc/articles/PMC9292973/ /pubmed/34647653 http://dx.doi.org/10.1002/hed.26894 Text en © 2021 The Authors. Head & Neck published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Re, Massimo
Tomasetti, Marco
Monaco, Federica
Amati, Monica
Rubini, Corrado
Sollini, Giacomo
Bajraktari, Arisa
Gioacchini, Federico Maria
Santarelli, Lory
Pasquini, Ernesto
MiRNome analysis identifying miR‐205 and miR‐449a as biomarkers of disease progression in intestinal‐type sinonasal adenocarcinoma
title MiRNome analysis identifying miR‐205 and miR‐449a as biomarkers of disease progression in intestinal‐type sinonasal adenocarcinoma
title_full MiRNome analysis identifying miR‐205 and miR‐449a as biomarkers of disease progression in intestinal‐type sinonasal adenocarcinoma
title_fullStr MiRNome analysis identifying miR‐205 and miR‐449a as biomarkers of disease progression in intestinal‐type sinonasal adenocarcinoma
title_full_unstemmed MiRNome analysis identifying miR‐205 and miR‐449a as biomarkers of disease progression in intestinal‐type sinonasal adenocarcinoma
title_short MiRNome analysis identifying miR‐205 and miR‐449a as biomarkers of disease progression in intestinal‐type sinonasal adenocarcinoma
title_sort mirnome analysis identifying mir‐205 and mir‐449a as biomarkers of disease progression in intestinal‐type sinonasal adenocarcinoma
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292973/
https://www.ncbi.nlm.nih.gov/pubmed/34647653
http://dx.doi.org/10.1002/hed.26894
work_keys_str_mv AT remassimo mirnomeanalysisidentifyingmir205andmir449aasbiomarkersofdiseaseprogressioninintestinaltypesinonasaladenocarcinoma
AT tomasettimarco mirnomeanalysisidentifyingmir205andmir449aasbiomarkersofdiseaseprogressioninintestinaltypesinonasaladenocarcinoma
AT monacofederica mirnomeanalysisidentifyingmir205andmir449aasbiomarkersofdiseaseprogressioninintestinaltypesinonasaladenocarcinoma
AT amatimonica mirnomeanalysisidentifyingmir205andmir449aasbiomarkersofdiseaseprogressioninintestinaltypesinonasaladenocarcinoma
AT rubinicorrado mirnomeanalysisidentifyingmir205andmir449aasbiomarkersofdiseaseprogressioninintestinaltypesinonasaladenocarcinoma
AT sollinigiacomo mirnomeanalysisidentifyingmir205andmir449aasbiomarkersofdiseaseprogressioninintestinaltypesinonasaladenocarcinoma
AT bajraktariarisa mirnomeanalysisidentifyingmir205andmir449aasbiomarkersofdiseaseprogressioninintestinaltypesinonasaladenocarcinoma
AT gioacchinifedericomaria mirnomeanalysisidentifyingmir205andmir449aasbiomarkersofdiseaseprogressioninintestinaltypesinonasaladenocarcinoma
AT santarellilory mirnomeanalysisidentifyingmir205andmir449aasbiomarkersofdiseaseprogressioninintestinaltypesinonasaladenocarcinoma
AT pasquiniernesto mirnomeanalysisidentifyingmir205andmir449aasbiomarkersofdiseaseprogressioninintestinaltypesinonasaladenocarcinoma